Clinical investigation of medicinal products for the treatment of attention deficit hyperactivity disorder (ADHD)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/431734/2008
Published05/08/2010
Effective from01/02/2011
KeywordsAttention deficit hyperactivity disorder (ADHD), children, adults, psychostimulants
DescriptionThis document provides guidance on the evaluation of new medicinal products for the treatment of attention deficit hyperactivity disorder with focus on the childhood onset.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper 

In operation: 01/02/2011–present


Published: 05/08/2010


Published: 18/12/2008


Published: 24/01/2008


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more